Skip to main content
graph.swiss
Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

39.27 CHF+0.00 (+0.00%)
XSWX:FREMarket Closed
ListedCHFHealthcareMedical Care Facilities177,783 employees

Company Profile

Legal NameFresenius SE & Co. KGaA
CEOMr. Michael Sen
HeadquartersElse-Kröner-Straße 1
Phone49 6172 6080
Employees (FTE)177,783
SectorHealthcare
IndustryMedical Care Facilities

Business Description

Fresenius SE & Co. KGaA is a global healthcare company headquartered in Bad Homburg, Germany. It delivers essential products and services for the treatment and care of critically and chronically ill patients across multiple segments. Fresenius Kabi specializes in biopharmaceuticals, clinical nutrition, medical technology products, intravenous generic drugs, and infusion therapies. Fresenius Helios operates as Europe's leading private hospital network, providing inpatient and outpatient medical care through facilities in Germany, Spain, and other regions. Fresenius Vamed offers comprehensive services for healthcare facilities, encompassing project management, planning, construction, maintenance, technical operations, and full facility management. The company also holds a significant stake in Fresenius Medical Care, which focuses on dialysis products and services for patients with chronic kidney disease. Operating in over 60 countries with an extensive production and distribution network, Fresenius SE & Co. KGaA plays a vital role in the healthcare sector by supporting key therapies in hospitals, clinics, and outpatient settings worldwide.

Profitability & Growth

Profitability

Profit Margin+6.40%
Operating Margin+10.22%
Return on Equity (TTM)+7.79%
Return on Assets (TTM)+3.33%

Recent Year-End

Revenue21.25B
Revenue / Share40.81
Gross Profit5.38B
EBITDA3.57B
Diluted EPS2.47
Earnings Growth YoY+90.00%
Revenue Growth YoY+2.00%

Balance Sheet Snapshot

Total Cash (MRQ)

1.90B

Total Debt (MRQ)

11.01B

Current Ratio (MRQ)

1.26

Book Value / Share

32.42

Stock Statistics

Shares Outstanding563.2M
Float Shares410.6M
Avg Volume (10d)62
Avg Volume (90d)1
% Held by Insiders+27.02%
% Held by Institutions+46.11%

Valuation

Enterprise Value30.18B
Trailing P/E14.52
PEG Ratio0.17
Price / Book (MRQ)1.11
EV / Revenue1.42
EV / EBITDA10.76

Price Summary

52-Week Low33.35
52-Week High46.36
50-Day MA35.93
200-Day MA39.89
Beta0.82

Dividends

Forward Div Rate0.96
Forward Div Yield+2.44%
Trailing Div Rate1.05
5Y Avg Div Yield+113.00%
Ex-Dividend Date2026-05-26